Homepage
PR Newswire
TalkMed @ 45cents
Thanks WJ. On second thought, it's true that we ought to be grateful of what Dr Ang had been doing. As what we had read so far, Dr Ang has a good vision and plan. Unfortunately, as a TalkMed shareholders, the vision and plan does not pen out as expected.
Sad. But, I guess, I will just take the 2% annual returns and move forward.
Again, as per the info given, looking forward to be a shareholders again when the new TalkMed is listed - hopefully soon.
Dr. Ang Peng Tiam, CEO of TalkMed, said: “This partnership is an extraordinary opportunity to improve care for cancer patients. The combined entity opens up opportunities for collaboration within a bigger oncology network.
This means improved access to innovative treatments and a wider range of deep medical expertise. Taken together, this will truly transform the way we treat patients, giving them more options and improved outcomes, in line with Singapore’s ambition as a centre of excellence in oncology.”
Gratitude!
Thanks WJ. On second thought, it's true that we ought to be grateful of what Dr Ang had been doing. As what we had read so far, Dr Ang has a good vision and plan. Unfortunately, as a TalkMed shareholders, the vision and plan does not pen out as expected.
Sad. But, I guess, I will just take the 2% annual returns and move forward.
Again, as per the info given, looking forward to be a shareholders again when the new TalkMed is listed - hopefully soon.
Dr. Ang Peng Tiam, CEO of TalkMed, said: “This partnership is an extraordinary opportunity to improve care for cancer patients. The combined entity opens up opportunities for collaboration within a bigger oncology network.
This means improved access to innovative treatments and a wider range of deep medical expertise. Taken together, this will truly transform the way we treat patients, giving them more options and improved outcomes, in line with Singapore’s ambition as a centre of excellence in oncology.”
Gratitude!